NOV. 28 – DEC. 2
2021 MUNICH
Vol. 38 No.6 • 10/2021
ISSN 1068-1760
I
N
T
MRI-Based Prostate Cancer Blood Test
P
rostate cancer does not usually cause any symptoms until the cancer has grown large enough to put pressure on the tube that carries urine from the bladder out of the penis (urethra). Symptoms of prostate cancer can include: needing to urinate more
E
R
N
A
T
I
DAILY CLINICAL LAB NEWS
®
O
End-to-End Digital Health Platform Automates Diagnostic Testing Process
A
new end-to-end digital health platform automates and simplifies diagnostic testing experience by transforming connectivity between clinical labs, providers, and patients, thus creating a testing ecosystem. PreciseMDX (Palo Alto, CA,
USA; www.precisemdx.com) has launched a cloud-based solution that automates and simplifies the diagnostic testing experience, empowering labs to deliver a transformative journey to providers and patients. PreciseMDX dramatically improves connectivity between
Cont’d on page 10
Cont’d on page 12
CRISPR Breakthrough Could Transform Antibody Testing
T
LINKXPRESS COM
R E A D E R
S E R V I C E
®
P O R T A L
Renew/Start your Free Subscription Access Interactive Digital Magazine Instant Online Product Information: LinkXpress codes of 1 Identify interest as you read magazine ®
on LinkXpress.com 2 toClick reach reader service portal Mark code(s) of interest on 3 LinkXpress inquiry matrix ®
If your subscription is not renewed every 12 months your Free Subscription may be automatically discontinued
Liquid Biopsy Detects Minute Brain Tumors
A
blood-based liquid biopsy approach enables detection of brain tumors that are so small and low-grade that the patient will often have few or no symptoms. Due to the non-specific symptoms of brain cancer, gliomas will often remain undetected until they are larger or at a higher grade, reducing the patient’s likelihood of a good clinical outcome.
here remains a substantial burden from infectious disease in low-resource rural communities, not least as a consequence of malaria. In infectious disease diagnosis, results need to be communicated rapidly to healthcare professionals once testing has been completed so that care pathways can be implemented. Diagnostic testing continues
Lead author, Karl Barber with a PICASSO microarray I
L
T
See article on page 17
S
A
Smartphone-Based DNA Test for Malaria
I
I
N
Cont’d on page 8
n an advance that could lead to a whole new class of clinical diagnostics, scientists have repurposed CRISPR genetic modification technology toward identifying antibodies in blood samples.
V
V I S I T
WORLD’S CLINICAL LABORATORY NEWS LEADER
High-Throughput PCR System Can Test Up to 150,000 COVID-19 Samples per Day
A
new ultra-high-throughput PCR testing system for SARS-CoV-2 detection can test up to 150,000 patient samples per day. The proven molecular genomics testing platform with unmatched capacity that has been developed by LGC, Biosearch Technologies (Hertfordshire, UK; www.biosearchtech.com) is expected
Cont’d on page 17
Driven by Evolution of New SARS-CoV-2 Strains, Antigen Testing Seen to Show Rapid Growth
T
he global COVID-19 antigen test market is witnessing increasing demand due to the evolution of new strains of the SARSCoV-2 virus and increasing spikes in the instances of new COVID-19 infections. These are the latest findings
of Transparency Market Research (Albany, NY, USA; www.trans parencymarketresearch.com), a next-generation market intelligence provider. Products in the global COVID19 antigen test market are expected to gain traction owing to Cont’d on page 13
Cont’d on page 12
INSIDE
COVID-19 Update. . . . . 4 Clinical News. . . . . . . . . 7 IFCC News. . . . . . . . . . 29 Product News . . . . . 6-26 Industry News . . . . . . . 33 Events Calendar . . . . . 34
PUBLISHED IN COOPERATION WITH
International Federation of Clinical Chemistry and Laboratory Medicine
GLOBETECH >>> MEDIA <<<